Sites of action of SKF 525-A in nerve and muscle.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001001:Anura; D001665:Binding Sites; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects; D004336:Drug Antagonism; D004357:Drug Synergism; D004492:Edetic Acid / Q000494:pharmacology; D004558:Electric Stimulation; D006863:Hydrogen-Ion Concentration; D009119:Muscle Contraction / Q000187:drug effects*; D009132:Muscles / Q000187:drug effects; D009431:Neural Conduction / Q000187:drug effects*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology*; D012584:Sciatic Nerve / Q000187:drug effects*; D013997:Time Factors
D009467:Neuromuscular Depolarizing Agents; D002110:Caffeine; D004492:Edetic Acid; D011335:Proadifen; D011188:Potassium; D002118:Calcium